GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » COGS-to-Revenue

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) COGS-to-Revenue : 0.27 (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co COGS-to-Revenue?

Tonghua Golden-horse Pharmaceutical Industry Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥80 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥296 Mil.

Tonghua Golden-horse Pharmaceutical Industry Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.27.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tonghua Golden-horse Pharmaceutical Industry Co's Gross Margin % for the three months ended in Mar. 2024 was 72.95%.

Tonghua Golden-horse Pharmaceutical Industry Co COGS-to-Revenue Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co COGS-to-Revenue Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.20 0.23 0.24 0.26

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.24 0.24 0.28 0.27

Tonghua Golden-horse Pharmaceutical Industry Co COGS-to-Revenue Calculation

Tonghua Golden-horse Pharmaceutical Industry Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=379.137 / 1473.345
=0.26

Tonghua Golden-horse Pharmaceutical Industry Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=79.942 / 295.573
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tonghua Golden-horse Pharmaceutical Industry Co  (SZSE:000766) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Tonghua Golden-horse Pharmaceutical Industry Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 79.942 / 295.573
=72.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Tonghua Golden-horse Pharmaceutical Industry Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » COGS-to-Revenue
Comparable Companies
SHSE:600420 SHSE:688276 SHSE:600285 SZSE:300558 SHSE:603456 SHSE:600572 SZSE:301015 SHSE:600750 SZSE:002399 SHSE:688192 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Website
http://www.thjm.cn
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines